SCOPE

"Scandium-based multifunctional nitrides for optoelectronic, polaritonic and ferro/magnetoelectric devices"

 Coordinatore IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 1˙486˙341 €
 EC contributo 1˙486˙341 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2012-StG_20111012
 Funding Scheme ERC-SG
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-11-01   -   2017-10-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

 Organization address address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ

contact info
Titolo: Dr.
Nome: Michelle Anna
Cognome: Moram
Email: send email
Telefono: +44 207 594 2587

UK (LONDON) hostInstitution 1˙486˙341.80
2    IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

 Organization address address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ

contact info
Titolo: Mr.
Nome: Shaun
Cognome: Power
Email: send email
Telefono: +44 207 594 8773
Fax: +44 207 594 8609

UK (LONDON) hostInstitution 1˙486˙341.80

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

nitride    plan    epitaxy    materials    beam    theme    months    full    magnetic    created    first    structures    transition    technique    device    alloys    performance    sc    stage   

 Obiettivo del progetto (Objective)

'Device performance is ultimately limited by material properties. To break existing performance limits, I plan to develop a new multifunctional Sc-based nitride materials platform in which tuneable semiconducting, ferroelectric and magnetic functionalities may be achieved for the first time. I can then address three major challenges: (1) solving a 20-year-old problem in solid-state-lighting using highly efficient green light-emitters, (2) creating the first electrically pumped full-spectrum polaritonic lasers, and (3) developing an optimised artificial synapse for adaptive computing (plus similar related non-volatile memory devices). Combined, such advances could lead towards the “spintronics dream” of devices with integrated optoelectronic, photonic and magnetic functionality. Importantly, the mature growth and device processing technologies in place for conventional nitride semiconductors will allow rapid exploitation of this versatile new group of materials.

A theme is planned for each objective. At Stage 1 (months 1 – 30), I plan to grow and characterise crystalline thin films of the Sc-based nitrides relevant to each theme, aiming to control the structure and properties of the individual layers and simple heterostructures from which devices will be constructed. Themes 1 and 2 will use specific Sc/III-nitride alloys created by molecular beam epitaxy, a flexible industry-proven growth technique. Theme 3 will explore and use a broad range of transition-metal/ScGaN alloys created by electron-beam epitaxy, a relatively low-cost technique optimised for transition metals. Full experimental data on layer properties will be input into models, which will be used to design full device structures. Optimised device designs will be chosen at Month 30. At Stage 2 (months 31 – 60), test structures will be created, processed and characterised, mostly using techniques already established for III-nitride semiconductor devices, leading to working prototype devices for each theme.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

SCADAPT (2012)

"Large-scale Adaptive Sensing, Learning and Decision Making: Theory and Applications"

Read More  

NONEQ.STEEL (2012)

Controlling Non-Equilibrium in Steels

Read More  

P73CANCER (2010)

p73 dependence in cancer: from molecular mechanisms to therapeutic targeting

Read More